Skip to main content

Table 1 Measures, variables, and timeline

From: Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: A protocol for a clustered, randomized clinical trial

Instrument

Assessment area

Time(s) of assessments

Sampling form

Inclusion/exclusion criteria

Before randomization

Sociodemographic data form

Sociodemographic data: age, gender, educational level, labor status, marital status, number of persons living in the home, disabled persons under his/her care.

At baseline

Baseline clinical data form

Identification of consumed benzodiazepines

At baseline

 

Dosage and duration of benzodiazepines consumed

 
 

Original reason for taking benzodiazepines

 
 

Comorbid chronic physical or psychological diseases

 

Benzodiazepine Severity of Dependence Scale (SDS)

Severity of benzodiazepine dependence

At baseline

Hospital Anxiety and Depression Scale (HADS)

Symptoms of anxiety and depression

At baseline, 6 and 12 months

Oviedo Sleep Quality Scale (COS)

Sleep quality and features

At baseline, 6 and 12 months

Alcohol consumption form

Alcohol consumption

At baseline, 6 and 12 months

Antidepressant consumption form

Current consumption of antidepressants

At baseline, 6 and 12 months

Current use of benzodiazepine form

Current consumption of benzodiazepines

At baseline, 6 and 12 months

Adverse effects form

Adverse effects related to benzodiazepine withdrawal

At 6 and 12 months

Use of health resources questionnaire

Number of primary care visits related to tapering of benzodiazepines

At 12 months